TY - JOUR AB - Subsequently to the publication of the above article, the authors have found that Fig. 4A on p. 1532 contained some errors. Owing to mistakes made during the preparation and revision of the manuscript, the invasion assay data images selected to show both the ‘Control’ and ‘shRNA2’ groups of the invasion and migration experiments were derived from the same original sources.
A corrected version of the Fig. 4, showing the correct data for the invasion and migration assay experiments with the Control and shRNA2 groups, is shown below. These inadvertent errors did not affect the conclusions reported in this paper, and all the authors agree with this Corrigendum. The authors thank the editor of Oncology Reports for presenting them with the opportunity to publish this Corrigendum, and apologize to the editor and to the readership of the journal for any inconvenience caused. [the original article was published in Oncology Reports 42: 1527-1538, 2019; DOI: 10.3892/or.2019.7257] AD - Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai 201102, P.R. China Shanghai Key Lab of Birth Defect, Children's Hospital of Fudan University, Shanghai 201102, P.R. China AU - Ye,Mujie AU - Ma,Jing AU - Liu,Baihui AU - Liu,Xiangqi AU - Ma,Duan AU - Dong,Kuiran DA - 2021/09/01 DO - 10.3892/or.2021.8156 IS - 3 JO - Oncol Rep KW - long non‑coding RNA neuroblastoma competing endogenous RNA PY - 2021 SN - 1021-335X 1791-2431 SP - 205 ST - [Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastoma T2 - Oncology Reports TI - [Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastoma UR - https://doi.org/10.3892/or.2021.8156 VL - 46 ER -